TGFB1 and cancer: The CpG methylations of RUNX3 and TGF-β were increased in the metastatic renal cancer model (Fig. 4a), while the global methylations of RUNX3 and TGF-β were decreased (Fig. 4b), consistent with the human cancer tissue results.